Ultragenyx Pharmaceutical reported $856.6M in Current Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Aptinyx Inc APTX:US $ 106.53M 8.22M
Biocryst Pharmaceuticals BCRX:US $ 511.71M 54.42M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
IONIS PHARMACEUT IONS:US $ 2345M 189.26M
Kyowa Hakko Kirin 4151:JP Y 498376M 19855M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Vital Therapies VTL:US $ 115.88M 10.89M
Xoma XOMA:US $ 89.61M 7.36M